1998
DOI: 10.1021/jm970658w
|View full text |Cite
|
Sign up to set email alerts
|

Biologically Active Oligodeoxyribonucleotides. 5. 5‘-End-Substituted d(TGGGAG) Possesses Anti-Human Immunodeficiency Virus Type 1 Activity by Forming a G-Quadruplex Structure

Abstract: A series of hexadeoxyribonucleotides (6-mers), d(TGGGAG), substituted with a variety of aromatic groups at the 5'-end were synthesized and tested for anti-human immunodeficiency virus type 1 (HIV-1) activity. While unmodified d(TGGGAG) (31) had no anti-HIV-1 activity, compound 23 with a 3,4-di(benzyloxy)benzyl (DBB) group at the 5'-end potently inhibited the HIV-1IIIB-induced cytopathicity of MT-4 cells in vitro (IC50 = 0.37 microM) without cytotoxicity up to 40 microM. A thermal denaturation study on the 5'-e… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1

Citation Types

7
67
0

Year Published

2000
2000
2023
2023

Publication Types

Select...
8

Relationship

0
8

Authors

Journals

citations
Cited by 87 publications
(75 citation statements)
references
References 31 publications
7
67
0
Order By: Relevance
“…These aptamers fold into defined three-dimensional (3D) structures and interact with HIV-1-associated proteins, such as HIV-1 reverse transcriptases (6,7), RNase H (8), Tat proteins (9), integrase (10)(11)(12)(13), and surface glycoproteins (14,15). A subcategory of aptamers possess an additional intermolecular assembly feature such as the quadruplex d(TGGGAG) 4 described by Hotoda et al, which was assembled by four 6-mer G-rich sequences in parallel with the 5=-end attaching to aromatic substituents of adequate size, such as tert-butyldiphenylsilyl (TBDPS) and 4=4-dimethoxytriphenyl (DMT) (16)(17)(18)(19)(20)(21)(22)(23)(24). These quadruplexes are aptamer-like since they interact with the V3 loop or the CD4 binding site on viral gp120, preventing viral adhesion and fusion with target cells (17,25,26).…”
mentioning
confidence: 99%
See 1 more Smart Citation
“…These aptamers fold into defined three-dimensional (3D) structures and interact with HIV-1-associated proteins, such as HIV-1 reverse transcriptases (6,7), RNase H (8), Tat proteins (9), integrase (10)(11)(12)(13), and surface glycoproteins (14,15). A subcategory of aptamers possess an additional intermolecular assembly feature such as the quadruplex d(TGGGAG) 4 described by Hotoda et al, which was assembled by four 6-mer G-rich sequences in parallel with the 5=-end attaching to aromatic substituents of adequate size, such as tert-butyldiphenylsilyl (TBDPS) and 4=4-dimethoxytriphenyl (DMT) (16)(17)(18)(19)(20)(21)(22)(23)(24). These quadruplexes are aptamer-like since they interact with the V3 loop or the CD4 binding site on viral gp120, preventing viral adhesion and fusion with target cells (17,25,26).…”
mentioning
confidence: 99%
“…Although there was no sequential specificity for the targeting interaction, the whole complex still needs to assemble into a rigid, defined framework possessing negative charges and hydrophobic groups. Specifically, the 5= hydrophobic group might contribute to the hydrophobic interactions (18). Based on the quadruplex model, we previously constructed several DNA quadruplex inhibitors containing TBDPS aromatic groups derived from the nucleobase at the 5=-end with similar HIV-1 fusion inhibitory activity.…”
mentioning
confidence: 99%
“…We introduced the 6-AZN to the G quartet PAS ON, synthesizing DBM 2200. DBM 2201 contains a dimethoxytrityl group on the 5Ј-end of the modified G-quadruplex in its PAO linkage, which was synthesized as described in previous reports (13,16,53). However, neither of these exhibited any significant anti-HIV-1 activity (Table 1).…”
Section: Resultsmentioning
confidence: 99%
“…The mechanisms suggested have included adsorption blocking (9,16,47,50,51,53) and inhibition of HIV-1-specific enzymes, such as reverse transcriptase (29)(30)(31) or integrase (21-23, 36, 42). However, most studies of the antiviral mechanisms of PAS ONs, as well as recent studies with small interfering RNA (siRNA) against HIV-1 (3,5,7,35,38,39,49), have been conducted by transfection or viral vector-mediated delivery (4,17,27,33,34), rather than simple treatment of the infected culture.…”
mentioning
confidence: 99%
“…GGGTGGGGTGGGTGGGT GGGCGGGCGGGCGGGC GIGTGGGTGGGTGGGT Do et al 2011 HIV-1 gp120 V3 loop TTGGGTT Wyatt et al 1994 HIV-1 gp120 V3 loop/CD4 binding site TGGGAG Hotoda et al 1998;Olieviero et al 2010 charged binding side at the ligands. This is largely due to the fact that the negative charge density of G-quadruplexes is twice as high as that of linear DNA (Gatto et al 2009), although other forces, such as Van der Waals, π-π stacking and hydrophobic interactions are also important.…”
Section: Target/name Sequence Of Aptamer ( 5´ → 3´) Referencesmentioning
confidence: 99%